Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for TransMedics (TMDX) over the last 7 years, with Q3 2025 value amounting to 0.11%.

  • TransMedics' Return on Capital Employed rose 700.0% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.05% for FY2024, which is 1200.0% up from last year.
  • Latest data reveals that TransMedics reported Return on Capital Employed of 0.11% as of Q3 2025, which was up 700.0% from 0.09% recorded in Q2 2025.
  • In the past 5 years, TransMedics' Return on Capital Employed ranged from a high of 0.11% in Q3 2025 and a low of 0.43% during Q2 2022
  • Moreover, its 5-year median value for Return on Capital Employed was 0.06% (2023), whereas its average is 0.11%.
  • As far as peak fluctuations go, TransMedics' Return on Capital Employed plummeted by -2200bps in 2022, and later skyrocketed by 4000bps in 2023.
  • Quarter analysis of 5 years shows TransMedics' Return on Capital Employed stood at 0.36% in 2021, then skyrocketed by 65bps to 0.12% in 2022, then skyrocketed by 64bps to 0.04% in 2023, then surged by 214bps to 0.05% in 2024, then surged by 124bps to 0.11% in 2025.
  • Its Return on Capital Employed stands at 0.11% for Q3 2025, versus 0.09% for Q2 2025 and 0.07% for Q1 2025.